Literature DB >> 20471366

Phosphorylation at serine 318 is not required for inhibition of T cell activation by ALX.

Michael J Shapiro1, Lynn Spruce, Rhianna Sundsbak, Puspa Thapa, Virginia Smith Shapiro.   

Abstract

The activation of T cells and the initiation of an immune response is tightly controlled by both positive and negative regulators. Two adaptors which function as negative regulators of T cell activation are ALX and LAX. ALX constitutively associates with LAX in T cells, and T cells from mice deficient in ALX and LAX display similar hyper-responsiveness upon T cell receptor (TCR)/CD28 stimulation, including increased production of interleukin-2. During T cell activation, ALX is inducibly phosphorylated, however the site of ALX phosphorylation had not been previously identified and the role of phosphorylation in the inhibitory function of ALX was not known. Here, using mass spectrometry, we demonstrate that ALX is phosphorylated on a serine at position 318. Substitution of alanine for serine at this position (ALX S318A) leads to an abrogation of the mobility shift in ALX induced upon TCR/CD28 stimulation. However, ALX S318A retained the ability to bind to and stimulate tyrosine phosphorylation of LAX. In addition, overexpression of ALX S318A inhibited RE/AP activation upon TCR/CD28 stimulation to a similar extent as wild-type ALX. Therefore, although ALX is inducibly phosphorylated upon TCR/CD28 stimulation, this phosphorylation is not required for ALX to inhibit T cell activation. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471366      PMCID: PMC2897073          DOI: 10.1016/j.bbrc.2010.05.043

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

3.  LAB: a new membrane-associated adaptor molecule in B cell activation.

Authors:  Erin Janssen; Minghua Zhu; Weijia Zhang; Surapong Koonpaew; Weiguo Zhang
Journal:  Nat Immunol       Date:  2003-01-06       Impact factor: 25.606

4.  Molecular cloning of a novel gene encoding a membrane-associated adaptor protein (LAX) in lymphocyte signaling.

Authors:  Minghua Zhu; Erin Janssen; Kin Leung; Weiguo Zhang
Journal:  J Biol Chem       Date:  2002-09-30       Impact factor: 5.157

Review 5.  The T-cell-specific adapter protein family: TSAd, ALX, and SH2D4A/SH2D4B.

Authors:  Philip E Lapinski; Jennifer A Oliver; Jennifer N Bodie; Francesc Marti; Philip D King
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

6.  PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes.

Authors:  Z Sun; C W Arendt; W Ellmeier; E M Schaeffer; M J Sunshine; L Gandhi; J Annes; D Petrzilka; A Kupfer; P L Schwartzberg; D R Littman
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

7.  Cloning and characterization of ALX, an adaptor downstream of CD28.

Authors:  Tiffani A Greene; Penda Powell; Chima Nzerem; Michael J Shapiro; Virginia Smith Shapiro
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

8.  The ALX Src homology 2 domain is both necessary and sufficient to inhibit T cell receptor/CD28-mediated up-regulation of RE/AP.

Authors:  Michael J Shapiro; Penda Powell; Adanma Ndubuizu; Chima Nzerem; Virginia Smith Shapiro
Journal:  J Biol Chem       Date:  2004-07-28       Impact factor: 5.157

9.  Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling.

Authors:  Tomás Brdicka; Martin Imrich; Pavla Angelisová; Nadezda Brdicková; Ondrej Horváth; Jirí Spicka; Ivan Hilgert; Petra Lusková; Petr Dráber; Petr Novák; Niklas Engels; Jürgen Wienands; Luca Simeoni; Jan Osterreicher; Enrique Aguado; Marie Malissen; Burkhart Schraven; Václav Horejsí
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

10.  c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1.

Authors:  V S Shapiro; M N Mollenauer; W C Greene; A Weiss
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  1 in total

1.  Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.

Authors:  Mansi Saxena; Rachel L Sabado; Melissa La Mar; Hiroshi Mohri; Andres M Salazar; Hanqing Dong; Joel Correa Da Rosa; Martin Markowitz; Nina Bhardwaj; Elizabeth Miller
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.